Ligand Pharmaceuticals IncorporatedLGND expanded its existing partnership with SAGE Therapeutics, Inc. SAGE and announced that their global license and supply agreements will now include the use of Captisol for the development and commercialization of SAGE 689. Ligand received a
Ligand, SAGE Captisol Partnership to Also Include SAGE-689
